Kevin Church - Jun 8, 2021 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Vice President of Discovery
Signature
/s/ Glenna Mileson, Attorney in fact for Kevin Church
Stock symbol
ATHA
Transactions as of
Jun 8, 2021
Transactions value $
$3,278
Form type
4
Date filed
6/9/2021, 05:39 PM
Previous filing
Jun 10, 2021
Next filing
Jan 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Options Exercise $3.28K +3.15K +7.69% $1.04 44.1K Jun 8, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Options Exercise $0 -3.15K -100% $0.00* 0 Jun 8, 2021 Common Stock 3.15K $1.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option fully vested on September 1, 2016.